MCLAREN PROTON THERAPY CENTER TO BE FIRST IN THE WORLD TO TREAT PATIENTS WITH LEO CANCER CARE’S UPRIGHT PROTON THERAPY TECHNOLOGY
The McLaren Proton Therapy Center is poised to become the first in the world to deliver proton therapy to patients with Leo Cancer Care’s ground-breaking upright treatment technology. In a landmark agreement. Leo Cancer Care will install two upright units at the McLaren Proton Therapy Center in Flint, Michigan, with the first patients set to receive care via the innovative treatment delivery system within the next two years upon receipt of the FDA’s clearance for the technology.
The McLaren Proton Therapy Center, part of the Karmanos Cancer Institute at McLaren Flint, is already the largest proton center in Michigan. The new Leo Cancer Care technology will increase patient throughput, improving access to proton therapy for patients afflicted with cancer in Michigan and beyond.
PARTICLE THERAPY RETROFITS TO REDEFINE CANCER CARE AND DOUBLE PATIENT THROUGHPUT
One of the biggest reasons particle therapy is not readily accessible to everyone who would benefit from it is the large cost and space requirements associated with the construction and technology needed to deliver particle therapy. Leo Cancer Care has developed innovative upright radiation therapy solutions that are significantly smaller and less complex, meaning particle therapy can be more accessible than ever before.
McLaren Proton Therapy Center had allotted a significant amount of space to install a traditional rotating gantry to deliver proton therapy. This is where the partnership between Gresham Smith and Leo Cancer Care began as they collaborated to show McLaren Proton Therapy Center that this single treatment room could become two treatment rooms if they installed the Leo Cancer Care, Marie™ solution.
Upright Treatment Planning - RaySearch and Leo Cancer Care
It is an exciting start for the partnership between RaySearch and Leo Cancer Care as McLaren Proton Therapy Center in Flint announces they will be utilizing RayStation® as their treatment planning software.
Johan Löf, founder and CEO of RaySearch, says:
“We look forward to collaborating with the McLaren Proton Center on both conventional proton therapy and exciting new treatment approaches. RaySearch recently announced a partnership with Leo Cancer Care, and the implementation of RayStation in the McLaren center will enable the center to fully utilize this technology."